Sale of 1,600 shares at $63.6850 per share.
Reporting Person Inrig Jula · Officer Title EVP, Head of R&D & CMO · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001902368-26-000008 · filed 2026-09-17 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Travere Therapeutics, Inc. (TVTX)." Disclosed 2026-09-17. https://desqlong.com/cards/0001902368-26-000008-4 (retrieved 2026-09-26).